Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. 1991

S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA 02115.

Previous reports have shown that one copy of the chromosome 17 was frequently lost in human ovarian cancers (1). The position of the allelic deletion has not been mapped and involvement of p53 gene has not been determined. In this study, we have shown that in human ovarian carcinoma, the commonest region of allelic loss in chromosome 17p is 17p 13.3 (65%) and 17p13.1 (63.7%; 6 out of 9 informative cases). Allelic loss was also observed at region 17p12 - 11.1 but at a lower frequency (38.6% to 37.5%). The pattern of allelic loss of p53 gene was consistent in both primary and secondary metastatic tumors of the same patient. No gross rearrangement of p53 was however observed at the remaining allele using Southern blot analysis. Allelic loss of p53 gene was closely associated with 17p 13.3, the terminal portion of chromosome 17p. The high frequency of allelic loss of p53 gene in ovarian carcinomas conformed with recent findings in cancers of colon, breast, lung and brain suggesting inactivation of p53 gene play a rate limiting step in pathogenesis of human malignancies.

UI MeSH Term Description Entries
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002871 Chromosome Banding Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping. Banding, Chromosome,Bandings, Chromosome,Chromosome Bandings
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002886 Chromosomes, Human, Pair 17 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 17
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D015342 DNA Probes Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections. Chromosomal Probes,DNA Hybridization Probe,DNA Probe,Gene Probes, DNA,Conserved Gene Probes,DNA Hybridization Probes,Whole Chromosomal Probes,Whole Genomic DNA Probes,Chromosomal Probes, Whole,DNA Gene Probes,Gene Probes, Conserved,Hybridization Probe, DNA,Hybridization Probes, DNA,Probe, DNA,Probe, DNA Hybridization,Probes, Chromosomal,Probes, Conserved Gene,Probes, DNA,Probes, DNA Gene,Probes, DNA Hybridization,Probes, Whole Chromosomal
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene

Related Publications

S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
October 1991, Cancer research,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
September 1995, International journal of oncology,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
January 1994, Cancer,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
November 1994, The Journal of pathology,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
September 1993, Journal of the National Cancer Institute,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
July 1993, Cancer,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
February 1996, Cancer research,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
April 1996, Cancer,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
January 1997, British journal of cancer,
S W Tsao, and C H Mok, and K Oike, and M Muto, and H M Goodman, and E E Sheets, and R S Berkowitz, and R C Knapp, and C C Lau
October 1991, Cancer research,
Copied contents to your clipboard!